CHICAGO (WLS) -- The Food and Drug Administration has signed off on the first continuous glucose monitor to be available without a prescription. Stelo, made by the company Dexcom, is a small sensor ...
SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that Stelo, the first over-the-counter ...
Stelo will be the first glucose biosensor in the US cleared for use without a prescription Indicated for use for people 18 years and older who are not using insulin therapy A small, wearable sensor ...
Find out why Dexcom Stelo made this year's list ...
Dexcom on Tuesday announced that its new over-the-counter continuous glucose monitor named Stelo has been cleared for use by the U.S. Food and Drug Administration, and it will be available for ...
San Diego’s Dexcom began sales this week of Stelo, the industry’s first FDA-approved continuous glucose monitor that doesn’t require a prescription. With a two-pack of the biosensor costing just under ...
An over-the-counter continuous glucose monitoring (CGM) solution developed by Dexcom called Stelo has received clearance from the Food and Drug Administration (FDA). Available without the need for a ...
Dexcom on Tuesday announced that its new over-the-counter continuous glucose monitor called Stelo has been cleared for use by the FDA. The new CGM is designed for patients with Type 2 diabetes who do ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback